FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2006030624> ?p ?o ?g. }

• W2006030624 endingPage "1059" @default.
• W2006030624 startingPage "1050" @default.
• W2006030624 abstract "Background Asymmetric dimethylarginine (ADMA) and subclinical inflammation are associated with atherosclerosis progression, whereas microalbuminuria is an established index of hypertensive organ damage. Study Design Cross-sectional. Setting & Participants In an outpatient hypertensive unit, 296 nondiabetic and untreated participants with hypertension were studied. Participants with atherosclerotic cardiovascular disease, severe valvulopathy, congestive heart failure, presence of neoplastic or other concurrent systemic disease, atrial fibrillation, serum creatinine level > 1.5 mg/dL in men and > 1.4 mg/dL in women, and urinary albumin excretion > 300 mg/24 h were excluded. Predictors ADMA and high-sensitivity C-reactive protein (hs-CRP) levels. Outcome Variable Albuminuria assessed using albumin-creatinine ratio (ACR). Measurements Participants underwent ambulatory blood pressure monitoring, echocardiography, routine assessment of metabolic profile, ADMA, and hs-CRP, whereas ACR was determined as the mean of 3 values in nonconsecutive morning spot urine samples. Results 64 participants had an ACR of 30-300 mg/g. Stratification based on ADMA level showed that participants with hypertension in quartile [Q] 4 compared with those in Q3, Q2, and Q1 showed the highest ACRs (53.2 vs 31.2 vs 30.4 vs 16.7 mg/g; P < 0.008 for all). Moreover, stratification based on hs-CRP level showed that participants with hypertension in Q4 (69.8% had microalbuminuria) showed the highest ACRs (72.2 vs 25.6, 16.2, and 19.2 mg/g for Q3, Q2, and Q1, respectively; P < 0.008 for all). Stepwise regression analysis showed that age, 24-hour systolic blood pressure, hs-CRP level, ADMA level, and the interaction of hs-CRP with ADMA were independent predictors of ACR (R2 = 0.674; P < 0.001). Limitations Cross-sectional study. Conclusions In patients with untreated essential hypertension, increased hs-CRP and ADMA levels are associated with microalbuminuria, suggesting the involvement of inflammation and endothelial dysfunction in vascular and kidney damage. Asymmetric dimethylarginine (ADMA) and subclinical inflammation are associated with atherosclerosis progression, whereas microalbuminuria is an established index of hypertensive organ damage. Cross-sectional. In an outpatient hypertensive unit, 296 nondiabetic and untreated participants with hypertension were studied. Participants with atherosclerotic cardiovascular disease, severe valvulopathy, congestive heart failure, presence of neoplastic or other concurrent systemic disease, atrial fibrillation, serum creatinine level > 1.5 mg/dL in men and > 1.4 mg/dL in women, and urinary albumin excretion > 300 mg/24 h were excluded. ADMA and high-sensitivity C-reactive protein (hs-CRP) levels. Albuminuria assessed using albumin-creatinine ratio (ACR). Participants underwent ambulatory blood pressure monitoring, echocardiography, routine assessment of metabolic profile, ADMA, and hs-CRP, whereas ACR was determined as the mean of 3 values in nonconsecutive morning spot urine samples. 64 participants had an ACR of 30-300 mg/g. Stratification based on ADMA level showed that participants with hypertension in quartile [Q] 4 compared with those in Q3, Q2, and Q1 showed the highest ACRs (53.2 vs 31.2 vs 30.4 vs 16.7 mg/g; P < 0.008 for all). Moreover, stratification based on hs-CRP level showed that participants with hypertension in Q4 (69.8% had microalbuminuria) showed the highest ACRs (72.2 vs 25.6, 16.2, and 19.2 mg/g for Q3, Q2, and Q1, respectively; P < 0.008 for all). Stepwise regression analysis showed that age, 24-hour systolic blood pressure, hs-CRP level, ADMA level, and the interaction of hs-CRP with ADMA were independent predictors of ACR (R2 = 0.674; P < 0.001). Cross-sectional study. In patients with untreated essential hypertension, increased hs-CRP and ADMA levels are associated with microalbuminuria, suggesting the involvement of inflammation and endothelial dysfunction in vascular and kidney damage." @default.
• W2006030624 created "2016-06-24" @default.
• W2006030624 creator A5005228083 @default.
• W2006030624 creator A5006768022 @default.
• W2006030624 creator A5017305680 @default.
• W2006030624 creator A5018860589 @default.
• W2006030624 creator A5024174746 @default.
• W2006030624 creator A5035609575 @default.
• W2006030624 creator A5043591193 @default.
• W2006030624 creator A5062855002 @default.
• W2006030624 creator A5064332172 @default.
• W2006030624 creator A5065539150 @default.
• W2006030624 date "2010-06-01" @default.
• W2006030624 modified "2023-09-26" @default.
• W2006030624 title "ADMA, C-Reactive Protein, and Albuminuria in Untreated Essential Hypertension: A Cross-sectional Study" @default.
• W2006030624 cites W1983760122 @default.
• W2006030624 cites W1995271132 @default.
• W2006030624 cites W2006197728 @default.
• W2006030624 cites W2014510807 @default.
• W2006030624 cites W2015511799 @default.
• W2006030624 cites W2027832056 @default.
• W2006030624 cites W2027993710 @default.
• W2006030624 cites W2029257292 @default.
• W2006030624 cites W2037655806 @default.
• W2006030624 cites W2037709367 @default.
• W2006030624 cites W2040643466 @default.
• W2006030624 cites W2045605650 @default.
• W2006030624 cites W2048246006 @default.
• W2006030624 cites W2052353914 @default.
• W2006030624 cites W2052893052 @default.
• W2006030624 cites W2057945182 @default.
• W2006030624 cites W2069935637 @default.
• W2006030624 cites W2072119028 @default.
• W2006030624 cites W2077634097 @default.
• W2006030624 cites W2080105057 @default.
• W2006030624 cites W2083691344 @default.
• W2006030624 cites W2089313777 @default.
• W2006030624 cites W2091349568 @default.
• W2006030624 cites W2099988883 @default.
• W2006030624 cites W2102816917 @default.
• W2006030624 cites W2107031719 @default.
• W2006030624 cites W2109371801 @default.
• W2006030624 cites W2118164052 @default.
• W2006030624 cites W2119869567 @default.
• W2006030624 cites W2132464590 @default.
• W2006030624 cites W2147624902 @default.
• W2006030624 cites W2148531805 @default.
• W2006030624 cites W2159359344 @default.
• W2006030624 cites W2164123970 @default.
• W2006030624 cites W2171151964 @default.
• W2006030624 cites W2171240706 @default.
• W2006030624 cites W2303651371 @default.
• W2006030624 cites W2990123797 @default.
• W2006030624 doi "https://doi.org/10.1053/j.ajkd.2009.11.024" @default.
• W2006030624 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20189274" @default.
• W2006030624 hasPublicationYear "2010" @default.
• W2006030624 type Work @default.
• W2006030624 sameAs 2006030624 @default.
• W2006030624 citedByCount "54" @default.
• W2006030624 countsByYear W20060306242012 @default.
• W2006030624 countsByYear W20060306242013 @default.
• W2006030624 countsByYear W20060306242014 @default.
• W2006030624 countsByYear W20060306242015 @default.
• W2006030624 countsByYear W20060306242016 @default.
• W2006030624 countsByYear W20060306242017 @default.
• W2006030624 countsByYear W20060306242018 @default.
• W2006030624 countsByYear W20060306242019 @default.
• W2006030624 countsByYear W20060306242020 @default.
• W2006030624 countsByYear W20060306242021 @default.
• W2006030624 countsByYear W20060306242022 @default.
• W2006030624 crossrefType "journal-article" @default.
• W2006030624 hasAuthorship W2006030624A5005228083 @default.
• W2006030624 hasAuthorship W2006030624A5006768022 @default.
• W2006030624 hasAuthorship W2006030624A5017305680 @default.
• W2006030624 hasAuthorship W2006030624A5018860589 @default.
• W2006030624 hasAuthorship W2006030624A5024174746 @default.
• W2006030624 hasAuthorship W2006030624A5035609575 @default.
• W2006030624 hasAuthorship W2006030624A5043591193 @default.
• W2006030624 hasAuthorship W2006030624A5062855002 @default.
• W2006030624 hasAuthorship W2006030624A5064332172 @default.
• W2006030624 hasAuthorship W2006030624A5065539150 @default.
• W2006030624 hasConcept C113280763 @default.
• W2006030624 hasConcept C126322002 @default.
• W2006030624 hasConcept C134018914 @default.
• W2006030624 hasConcept C149323552 @default.
• W2006030624 hasConcept C159641895 @default.
• W2006030624 hasConcept C164705383 @default.
• W2006030624 hasConcept C185592680 @default.
• W2006030624 hasConcept C2776174234 @default.
• W2006030624 hasConcept C2776914184 @default.
• W2006030624 hasConcept C2777097880 @default.
• W2006030624 hasConcept C2777468819 @default.
• W2006030624 hasConcept C2779877776 @default.
• W2006030624 hasConcept C2780306776 @default.
• W2006030624 hasConcept C2781195455 @default.
• W2006030624 hasConcept C2781203188 @default.
• W2006030624 hasConcept C3020110884 @default.
• W2006030624 hasConcept C515207424 @default.

• next